See the DrugPatentWatch profile for Xeljanz
The cost of Xeljanz with insurance can vary significantly based on a person's specific insurance plan, including their deductible, copay, and coinsurance. Many commercial insurance plans may offer some coverage for Xeljanz, but patients often have out-of-pocket costs.
How can I get help with Xeljanz costs?
For commercially insured patients, Pfizer, the manufacturer of Xeljanz, offers a savings program. This program may reduce out-of-pocket costs to as low as $0 for eligible patients. Eligibility requirements and program terms apply [1].
What if I have Medicare or Medicaid?
Medicare and Medicaid coverage for Xeljanz also varies by plan and state. Patients with these government-sponsored insurance programs should contact their plan provider directly to understand their specific coverage and potential out-of-pocket expenses.
What is the list price of Xeljanz?
The list price, or wholesale acquisition cost, of Xeljanz is not directly reflective of what patients pay with insurance. This price is typically what pharmacies are charged by the manufacturer. For current list price information, individuals may need to consult drug pricing databases or inquire with their pharmacy.
How does Xeljanz compare to other treatments for my condition?
Xeljanz is a Janus kinase (JAK) inhibitor used to treat conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Other treatment options for these conditions include other classes of medications like biologic DMARDs (e.g., TNF inhibitors) and conventional synthetic DMARDs. The choice of treatment often depends on the specific condition, its severity, and individual patient factors, including response to previous therapies and potential side effects [2].
When does the Xeljanz patent expire?
Information regarding Xeljanz patent expiry dates can be found on specialized patent tracking websites. For example, DrugPatentWatch.com tracks patent information for many drugs, including Xeljanz [3]. Patent expiry is a key factor in the potential development of generic versions of the drug.
Are there generic versions of Xeljanz available?
Currently, there are no generic versions of Xeljanz available. The development and approval of generic medications are contingent upon patent expiry and regulatory review processes.
What are the common side effects of Xeljanz?
Common side effects reported for Xeljanz can include upper respiratory tract infections, headache, and diarrhea. Serious side effects can also occur, and patients are advised to discuss these risks thoroughly with their healthcare provider [2].
How much does Xeljanz cost without insurance?
Without insurance, the cost of Xeljanz can be substantial. Patients without prescription drug coverage would be responsible for the full retail price of the medication, which can run into thousands of dollars per month. Assistance programs from the manufacturer are generally not available for those without any prescription drug insurance.
Sources:
[1] https://www.xeljanz.com/savings-and-support.html
[2] https://www.xeljanz.com/rheumatoid-arthritis/about-xeljanz.html
[3] https://www.drugpatentwatch.com/